Jama Intern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jama intern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jama Intern Today - Breaking & Trending Today

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes

Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes. ....

Julie Paik , Us Centers For Disease , Centers For Disease , Harvard Medical School , Women Hospital Harvard Medical School Julie Paik , Disease Control , Clinformatics Data Mart Database , Medicare Fee For Service Parts , Glucose Cotransporter , Nephrolithiasis Risk , Patients With Type , Jama Intern , Chronic Kidney , Kidney Stone , Type 2 Diabetes , Sodium Glucose Cotransporter 2 Inhibitor , Glucagon Like Peptide 1 Receptor Agonist , Glp 1ra , Dipeptidyl Peptidase 4 Inhibitor ,